Comparison of Carvedilol and Propranolol in the Treatment of Portal Hypertension in Cirrhosis

Authors

  • TALAT NAHEED KASHIF MAHMOOD MALIK M. NABEEL AKBAR

Keywords:

Liver cirrhosis, portal hypertension, carvedilol, propranolol

Abstract

Cirrhosis of liver is a major international and national health hazard that causes very significant morbidity and mortality in our country. In Pakistan, the commonest cause of liver cirrhosis is chronic viral hepatitis. Portal hypertension is one of the major complications of liver cirrhosis.4 Carvedilol is a nonselective blocker with 1-adrenergic blocking activity. It has been shown to decrease portal pressure in cirrhotic patients. Additionally, carvedilol has a greater portal hypotensive effect than propranolol alone in patients with cirrhosis.9 Objective: To compare the efficacy of carvedilol and propranolol for the treatment of portal hypertension in patients of liver cirrhosis. Study Design and Place of Study: It was a randomized clinical trial. This study was conducted in the Department of Medical Unit-II, Sir Ganga Ram Hospital, Lahore. It was six months study from 26th March to 26th September 2010. Materials and Methods: One hundred patients of liver cirrhosis with portal hypertension were selected for this study. The patients were randomly divided into group A and B by using lottery method. Group A patients were given propranolol 40mg and group B patients were given carvedilol 25mg. Portal flow velocity was measured before and 90 minutes after the administration of the above mentioned drugs by a radiologist on Doppler ultrasonography and more than 20% decrease was considered as efficacy. Results: The mean age of the patients in group A was 51.6±11.3 years and in group B was 54.6±9.4 years. In group A, there were 37 (74%) male and 13 (26%) female patients and in group B, there were 27 (54%) male and 23 (46%) female patients. In group A, there were 12 (24%) patients had efficacy of treatment and in group B, there were 26 (52%) patients had efficacy of treatment. Conclusion: It is concluded from this study that carvedilol is more effective than propranolol for the treatment of portal hypertension in patients of liver cirrhosis. As in our study carvedilol is effective in 52% patients and propranolol in 24% patients.

Downloads

Published

2018-07-15

How to Cite

1.
KASHIF MAHMOOD MALIK M. NABEEL AKBAR TN. Comparison of Carvedilol and Propranolol in the Treatment of Portal Hypertension in Cirrhosis. J Fatima Jinnah Med Univ [Internet]. 2018 Jul. 15 [cited 2024 May 4];5(2). Available from: https://jfjmu.com/index.php/ojs/article/view/485

Issue

Vol. 5 No. 2 (2011): Journal of Fatima Jinnah Medical College

Section

Articles

License

The Journal of Fatima Jinnah Medical University follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC By-NC license restricts the use of material for commercial purposes. For further details about the license please check the Creative Commons website. The editorial board of JFJMU strives hard for the authenticity and accuracy of the material published in the journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board.